MedTrace Logo

Grafting of Autologous Adipose Stromal Cell Trial

NCT02116933 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2015-05-13

No results posted yet for this study

Summary

Grafting of autologous stromal cell trial is a prospective study comparing routine fat grafting versus stromal vascular fraction enriched fat grafting.

Conditions

  • Micromastia

Interventions

PROCEDURE

Adipose Derived Stem Cells

Adipose derived stem cells harvested from autologous lipoaspirate

PROCEDURE

SVF Enriched Autologous Fat Grafting

Cell assisted lipotransfer

Sponsors & Collaborators

  • Tower Outpatient Surgical Center

    lead OTHER

Principal Investigators

  • Joel A Aronowitz, MD · Cedars-Sinai Medical Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2016-03-31
Completion
2016-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02116933 on ClinicalTrials.gov